Transvaginal Mesh Lawsuit Update: Rottenstein Law Group LLP Comments on Bard Mesh Trial Settlement in W. Va.

The firm is currently offering Bard transvaginal mesh lawsuit evaluations to women who allege they sustained injuries from transvaginal mesh implants.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
The firm is currently offering Bard transvaginal mesh lawsuit evaluations to women who allege they sustained injuries from transvaginal mesh implants.

The firm is currently offering Bard transvaginal mesh lawsuit evaluations to women who allege they sustained injuries from transvaginal mesh implants.

It would seem that the three verdicts for plaintiffs handed down in state and federal courts have sent a message to Bard: that it will be held accountable for the harms caused by its products.

(PRWEB) August 21, 2013

The second federal bellwether CR Bard transvaginal mesh trial ended after two days in a settlement between plaintiff Wanda Queen and the mesh maker for an undisclosed sum, according to an Aug. 21 Bloomberg story. The Rottenstein Law Group LLP, which represents clients in transvaginal mesh lawsuits, responds to the trial’s outcome.

Queen had claimed that her Bard Avaulta vaginal mesh caused her pain and forced her to have six surgeries, according to Bloomberg’s reporting on the lawsuit (Queen et al v. C. R. Bard, Inc.; 2:11-cv-00012, MDL-2187, U.S. District Court for the Southern District of West Virginia). This comes on the heels of a $2 million verdict against Bard last week. Bard faces more than 8,000 claims against it over the Avaulta, the article said.

“It would seem that the three verdicts for plaintiffs handed down in state and federal courts have sent a message to Bard: that it will be held accountable for the harms caused by its products,” said Rochelle Rottenstein, principal of the Rottenstein Law Group LLP. “It's not surprising, then, that Bard will try to settle cases now, if it can offer an acceptable amount to each plaintiff and avoid the costs of going to trial, expecting that each plaintiff is more likely than not to prevail. And settlements will allow Bard to avoid further punitive damages assessments, which can very quickly add up to a lot of money.”

Several mesh manufacturers are also defendants in several thousands of federal lawsuits consolidated for pretrial efficiency.** Another recent vaginal mesh award involving Bard included a 2012 verdict in California that resulted in a $5.5 million damages award*** to the plaintiff.

The Rottenstein Law Group LLP encourages those who believe they have suffered from the alleged side effects of their transvaginal mesh implants to download a free informational brochure from its website. Those who believe their mesh has injured them will find instructions and procedures for filing a vaginal mesh lawsuit, in addition to more information about side effects.

*bloomberg.com/news/2013-08-21/bard-settles-vaginal-mesh-case-after-2-million-verdict.html

**Mentor Corp., MDL-2004, U.S. District Court for the Middle District of Georgia. C.R. Bard, American Medical Systems, Boston Scientific, Ethicon, Coloplast and Cook Medical, MDLs-2187, 2325, 2326, 2327, 2387 and 2440, U.S. District Court for the Southern District of West Virginia.

***bloomberg.com/news/2012-07-24/bard-must-pay-5-5-million-over-vaginal-mesh-implants.html (July 24, 2012)

About THE ROTTENSTEIN LAW GROUP LLP
The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)

Contact:
The Rottenstein Law Group LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
# 804
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com

                            ###